Zydus Completes Cash Tender Offer for Assertio Holdings, Inc.
Ahmedabad: Zydus Lifesciences Ltd. announced the successful completion of a cash tender offer through its wholly owned subsidiary, Zara Merger Sub Inc., for all outstanding shares of common stock of Assertio Holdings, Inc. (Nasdaq: ASRT).The company and the Purchaser finalized the cash offer at a purchase price of $23.50 per share of common stock of Assertio, net of any required withholding taxes. As of the tender offer expiration on June 15, 2026, 4,286,488 shares of common stock were validly tendered and not withdrawn. This volume represents approximately 66.32% of the total issued and outstanding common stock of Assertio. Zydus stated that all such shares have been accepted for payment according to the tender offer terms, and the company anticipates promptly compensating these shareholders.
The acquisition is scheduled for completion on June 16, 2026. The transaction will be finalized through a merger involving the Purchaser with and into Assertio, with Assertio continuing as the surviving corporation. Following the merger, all shares of common stock that were not tendered in the offer will be cancelled and converted into the right to receive cash equivalent to the $23.50 offer price per common share, less any required withholding taxes.
Upon completion of the merger, Assertio Holdings will become a wholly owned subsidiary of Zydus Lifesciences Ltd., and its common stock will cease being listed or traded on the Nasdaq Global Market.
Zydus Lifesciences is an innovative global lifesciences company that discovers, develops, manufactures, and markets a wide range of healthcare therapies. The group employs over 29,000 people worldwide, including 1,500 scientists engaged in R&D, striving to transform lives through pathbreaking discoveries and quality healthcare solutions.
ZYDUSLIFE Stock Price Movement
Zydus Lifesciences Limited shares slipped today, shedding ₹7.30 or 0.67% to settle at ₹1078.7 in post-market trading. The stock closed after a choppy day, finishing near the lower end of its intraday range and recording a volume of 1.05 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.